TMEM219 Activators
TMEM219 activators encompass a category of chemical agents that are involved in the modulation of the transmembrane protein 219 (TMEM219), whose precise biological functions are subject to ongoing research within the scientific community. These activators may exert their effects through direct binding to the protein or indirectly by influencing the cellular pathways that control its activity. Direct activators of TMEM219 interact with specific regions of the protein, which may include its transmembrane domains or extracellular and intracellular loops. By binding to these regions, activators could induce conformational alterations that enhance the protein's activity or its ability to interact with other cellular components. Such direct activation could facilitate the normal functioning of TMEM219, including any role it may have in cellular signaling or as part of a larger protein complex.
Indirect TMEM219 activators may work by affecting the regulatory mechanisms that govern the protein's expression, stability, or post-translational modifications. For instance, these compounds could increase the transcription of the TMEM219 gene, stabilize the mRNA to enhance translation, or inhibit the degradation of the protein to maintain its presence in the membrane. Additionally, indirect activators might modulate the activity of kinases, phosphatases, or other enzymes that modify TMEM219 post-translationally, thereby affecting its function. Understanding the role of TMEM219 is vital for grasping its contribution to cellular physiology. As research progresses, TMEM219's involvement in cellular processes like signal transduction, transport mechanisms, or interactions with other membrane proteins could become clearer.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that suppresses the MAPK pathway, indirectly leading to TMEM219 activation as this pathway's suppression can enhance calcium release, a process in which TMEM219 is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that inhibits the PI3K/Akt pathway, thereby enhancing the role of TMEM219 in calcium homeostasis by lessening the competition for shared pathway components. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-beta receptor inhibitor that suppresses the TGF-beta pathway, thereby indirectly stimulating TMEM219's role in transmembrane transport by reducing competition for shared pathway components. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that suppresses the RhoA/ROCK pathway, thereby enhancing the role of TMEM219 in calcium release by lessening the competition for shared pathway components. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that suppresses the JNK pathway, thereby indirectly enhancing TMEM219's function in calcium homeostasis by reducing competition for shared pathway components. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that inhibits the PI3K/Akt pathway, indirectly enhancing the activity of TMEM219 by lessening the competition for shared pathway components. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that inhibits the mTOR pathway, thereby indirectly enhancing the functional activity of TMEM219 in transmembrane transport by reducing competition for shared pathway components. | ||||||
PD 153035 | 153436-54-5 | sc-205909 | 5 mg | $146.00 | 5 | |
EGFR inhibitor that suppresses the EGFR pathway, thereby indirectly enhancing the functional activity of TMEM219 in calcium homeostasis by reducing competition for shared pathway components. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that suppresses the p38 MAPK pathway, thereby indirectly enhancing the functional activity of TMEM219 in calcium release by reducing competition for shared pathway components. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor that suppresses the tyrosine kinase pathway, thereby indirectly enhancing the functional activity of TMEM219 in transmembrane transport by reducing competition for shared pathway components. | ||||||